Incidence of uterine bleeding following oral anticoagulant use in Food and Drug Administration’s Sentinel System
- 26 November 2020
- journal article
- editorial
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 224 (4), 403-404
- https://doi.org/10.1016/j.ajog.2020.11.034
Abstract
No abstract availableFunding Information
- U.S. Food and Drug Administration
This publication has 4 references indexed in Scilit:
- The FDA Sentinel Initiative — An Evolving National ResourceThe New England Journal of Medicine, 2018
- The FDA's sentinel initiative—A comprehensive approach to medical product surveillanceClinical Pharmacology & Therapeutics, 2015
- The U.S. Food and Drug Administration's Mini-Sentinel program: status and directionPharmacoepidemiology and Drug Safety, 2012
- Developing the Sentinel System — A National Resource for Evidence DevelopmentThe New England Journal of Medicine, 2011